Medicare Enrolled

Dr. Franck Rahaghi, M.D.

Pulmonary Disease · Weston, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2950 CLEVELAND CLINIC BLVD, Weston, FL 33331
9546595000
Registered in NPPES since 2006
NPI: 1730137597 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rahaghi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rahaghi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rahaghi

Dr. Franck Rahaghi is a pulmonary disease specialist in Weston, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rahaghi performed 682 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rahaghi received a total of $1,492,449 from 36 pharmaceutical and/or device companies across 2309 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rahaghi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 682 Medicare services $1,492,449 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 87748 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
682
Medicare services
Bottom 34% in FL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
244 $130 $402
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
87 $179 $1,276
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
67 $26 $169
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
49 $46 $201
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
48 $22 $358
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
48 $45 $204
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $104 $305
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
33 $99 $437
New patient office visit, complex (60-74 min) 25 $147 $668
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $103 $446
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
12 $145 $894
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
11 $32 $788
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,492,449
Total received (2018-2024)
Avg $213,207/year across 7 years
Top 0% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
2,309
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$61,578
2023
$214,813
2022
$271,977
2021
$214,812
2020
$157,483
2019
$281,593
2018
$290,192

Payments by company (2024)

Actelion Pharmaceuticals US, Inc.
$33,544
United Therapeutics Corporation
$14,291
Mallinckrodt Hospital Products Inc.
$8,676
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,725
Regeneron Healthcare Solutions, Inc.
$114
ANI Pharmaceuticals, Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$48
Novartis Pharmaceuticals Corporation
$33
Merck Sharp & Dohme LLC
$33
Top 3 companies account for 91.8% of 2024 payments
All-time payments by company (2018-2024) ›
United Therapeutics Corporation
$469,537
Mallinckrodt Hospital Products Inc.
$238,090
Actelion Pharmaceuticals US, Inc.
$165,736
Boehringer Ingelheim Pharmaceuticals, Inc.
$119,433
Mallinckrodt Enterprises LLC
$91,253
Grifols USA, LLC
$85,061
Bayer HealthCare Pharmaceuticals Inc.
$76,646
Takeda Pharmaceuticals U.S.A., Inc.
$63,763
Genentech USA, Inc.
$51,059
Mallinckrodt LLC
$49,646
Shire North American Group Inc
$24,426
Bayer Healthcare Pharmaceuticals Inc.
$9,973
Merck Sharp & Dohme LLC
$9,742
Exeltis, USA Inc.
$8,404
Genentech, Inc.
$6,076
ANI Pharmaceuticals, Inc.
$5,890
Gilead Sciences, Inc.
$4,537
Actelion Pharmaceuticals, Ltd
$3,375
AstraZeneca Pharmaceuticals LP
$2,890
CSL Behring
$2,350
GlaxoSmithKline, LLC.
$1,647
Grifols Shared Services North America, Inc.
$996
Sandoz Inc.
$509
Novartis Pharmaceuticals Corporation
$395
Insmed, Inc.
$260
Inari Medical, Inc.
$193
Regeneron Healthcare Solutions, Inc.
$147
PFIZER INC.
$119
Circassia Pharmaceuticals Inc
$101
Teva Pharmaceuticals USA, Inc.
$80
Theravance Biopharma, Inc.
$32
GENZYME CORPORATION
$24
Covidien LP
$17
Pulmonx Corporation
$17
Boston Scientific Corporation
$13
Inogen, Inc.
$11
Top 3 companies account for 58.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANORO · ANORO ELLIPTA · ARALAST · Actemra · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · DUAKLIR PRESSAIR · DUPIXENT · EXALT Model D · Esbriet · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Gamunex-C · HYQVIA · InogenOne · Letairis · NONE · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · QVAR · REMODULIN · S · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TUDORZA PRESSAIR · TYVASO · UPTRAVI · WINREVAIR · XOLAIR · Xembify · Xolair · ZEPHYR DELIVERY CATHETER · Zemaira · superDimension
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Weston?
Compare pulmonary diseases in the Weston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
138
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
CLEVELAND CLINIC HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rahaghi is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rahaghi experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Rahaghi performed 244 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rahaghi receive payments from pharmaceutical companies?
Yes. Dr. Rahaghi received a total of $1,492,449 from 36 companies across 2,309 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rahaghi's costs compare to other pulmonary diseases in Weston?
Dr. Rahaghi's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rahaghi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →